CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors.
Int J Mol Sci
; 23(18)2022 Sep 14.
Article
in En
| MEDLINE
| ID: mdl-36142595
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tay-Sachs Disease
/
Gangliosidoses, GM2
Limits:
Humans
Language:
En
Journal:
Int J Mol Sci
Year:
2022
Document type:
Article
Affiliation country:
Colombia
Country of publication:
Switzerland